Aljona Saleh
Forskare vid Institutionen för farmaci; UDOPP
- Telefon:
- 018-471 44 01
- E-post:
- aljona.saleh@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Ladda ned kontaktuppgifter för Aljona Saleh vid Institutionen för farmaci; UDOPP
Nyckelord
- analytical chemistry
- mass spectrometry
- chromatography
- bioanalysis
- adme
- biopharmaceutics
- high resolution mass spectromentry
- drug discovery and development platform scilifelab
- udopp

Publikationer
Senaste publikationer
-
Ingår i Nature Communications, 2026
- DOI för Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity
- Ladda ner fulltext (pdf) av Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity
-
Ingår i International Journal of Biological Macromolecules, 2026
- DOI för Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
- Ladda ner fulltext (pdf) av Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
-
Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
Ingår i Nature Communications, 2025
- DOI för Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
- Ladda ner fulltext (pdf) av Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
-
Ingår i Advanced Therapeutics, 2022
- DOI för An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
- Ladda ner fulltext (pdf) av An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
-
Ingår i Journal of chromatography. B, 2022
Alla publikationer
Artiklar i tidskrift
-
Ingår i Nature Communications, 2026
- DOI för Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity
- Ladda ner fulltext (pdf) av Docking of virtual libraries identifies small-molecule agonists of neurotensin receptors with analgesic activity
-
Ingår i International Journal of Biological Macromolecules, 2026
- DOI för Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
- Ladda ner fulltext (pdf) av Optimizing T cell responses of targeted peptide antigen delivery by modulating antigen processing through amino acid exchange
-
Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
Ingår i Nature Communications, 2025
- DOI för Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
- Ladda ner fulltext (pdf) av Ultra-large virtual screening unveils potent agonists of the neuromodulatory orphan receptor GPR139
-
Ingår i Advanced Therapeutics, 2022
- DOI för An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
- Ladda ner fulltext (pdf) av An Adaptable Antibody-Based Platform for Flexible Synthetic Peptide Delivery Built on Agonistic CD40 Antibodies
-
Ingår i Journal of chromatography. B, 2022
-
Ingår i Journal of Medicinal Chemistry, s. 3915-3934, 2020
- DOI för Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
- Ladda ner fulltext (pdf) av Optimization of Tetrahydroindazoles as Inhibitors of Human Dihydroorotate Dehydrogenase and Evaluation of Their Activity and In Vitro Metabolic Stability
-
Ingår i Nature Communications, 2018
- DOI för A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
- Ladda ner fulltext (pdf) av A DHODH inhibitor increases p53 synthesis and enhances tumor cell killing by p53 degradation blockage
-
Validation and development of MTH1 inhibitors for treatment of cancer
Ingår i Annals of Oncology, s. 2275-2283, 2016
- DOI för Validation and development of MTH1 inhibitors for treatment of cancer
- Ladda ner fulltext (pdf) av Validation and development of MTH1 inhibitors for treatment of cancer
-
Ingår i Chromatographia, s. 383-393, 2016
-
MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
Ingår i Nature, s. 215-221, 2014